Business
Director Dealing
Director Dealing.
About this update from Arecor Therapeutics Plc
[{"type":"text","content":"\n\nArecor Therapeutics plc\n \n(\"Arecor\", the \"Company\" or the \"Group\")\n \nDirector Dealing\n \nCambridge, UK, 14 May 2025. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today's therapies to enable healthier lives, today announces that Andrew Richards, Chair, has purchased 35,000 ordinary shares of £0.01 each in the capital of the Company (\"Ordinary Shares\") at a price of £0.4125 per Ordinary Share.\n \nFollowing the transaction, the total beneficial interest of Andrew Richards is 286,611 Ordinary Shares, representing 0.76% of the total voting rights.\n-ENDS-\n \nFor more information, please contact:\n \n\n\n\n\nArecor Therapeutics plc\n\n\nwww.arecor.com\n\n\n\n\nDr Sarah Howell, Chief Executive Officer\n\n\nTel: +44 (0) 1223 426060\nEmail: [email protected]\n\n\n\n\nDavid Ellam, Chief Financial Officer\n\n\nTel: +44 (0) 1223 426060\nEmail: [email protected] \n\n\n\n\n\n\n\n\n\n\n\n\nSinger Capital Markets Advisory LLP (NOMAD and Broker)\n\n\n\n\n\n\n\nPhil Davies, Sam Butcher\n\n\nTel: +44 (0) 20 7496 3000\n\n\n\n\n \n\n\n\n\n\n\n\nICR Healthcare\n\n\n\n\n\n\n\nChris Gardner, David Daley, Lindsey Neville\n\n\nTel: +44 (0) 20 3709 5700\nEmail: [email protected] \n\n\n\n\n \nNotes to Editors\n \nAbout Arecor\nArecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com\n \n \n \n \nNOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING\nMANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM\n \n\n\n\n\n 1\n\n\nDetails of the person discharging managerial responsibilities/person closely associated\n\n\n\n\na)\n\n\nName\n\n\nAndrew Richards\n\n\n\n\n2\n\n\nReason for the notification\n\n\n\n\na)\n\n\nPosition/status\n\n\nChair...